SG Americas Securities’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,210
Closed -$49K 3241
2025
Q4
$49K Buy
+10,210
New +$49.4K ﹤0.01% 3357
2025
Q2
Sell
-20,317
Closed -$55K 2965
2025
Q1
$55K Sell
20,317
-2,653
-12% -$9.52K ﹤0.01% 3216
2024
Q4
$98K Buy
22,970
+5,297
+30% +$20.2K ﹤0.01% 2751
2024
Q3
$52K Buy
+17,673
New +$56.3K ﹤0.01% 3238
2024
Q2
Sell
-20,607
Closed -$59K 2875
2024
Q1
$59K Sell
20,607
-11,029
-35% -$34K ﹤0.01% 2711
2023
Q4
$112K Buy
31,636
+5,652
+22% +$16.2K ﹤0.01% 2680
2023
Q3
$67K Buy
+25,984
New +$91.3K ﹤0.01% 2880
2023
Q2
Sell
-20,488
Closed -$69K 2346
2023
Q1
$69K Sell
20,488
-2,893
-12% -$11.8K ﹤0.01% 3011
2022
Q4
$84K Buy
23,381
+5,574
+31% +$23.8K ﹤0.01% 2762
2022
Q3
$72K Sell
17,807
-1,026
-5% -$5.27K ﹤0.01% 2928
2022
Q2
$84K Buy
+18,833
New +$136K ﹤0.01% 3177
2021
Q2
Sell
-11,566
Closed -$119K 2868
2021
Q1
$119K Buy
+11,566
New +$161K ﹤0.01% 2990

Other funds holding SRTA

SG Americas Securities's SRTA Position: Q1 2026 in Review

SG Americas Securities sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 10,210 shares — an estimated $49K sold.

SG Americas Securities first reported a position in SRTA in Q1 2021 and held it in 12 quarters. The position peaked at $119K in Q1 2021. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • SG Americas Securities reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 10,210 Strata Critical Medical Inc shares in Q1 2026, an estimated $49K.
  • SG Americas Securities first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 12 quarters.
  • SG Americas Securities's Strata Critical Medical Inc position peaked at $119K in Q1 2021.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.